The Quantellect read.As of Nov 19, 2026, 4 active firms cover Scotts Miracle-Gro Company: 3 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $60.00 to $75.00, so the covering firms are broadly aligned. The average target of $68.00 sits 6% above the current $64.09. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $4.48 next quarter toward $5.19 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy375%
Neutral125%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$68.00
+6.1% upside
Average target across 4 active firms as of Nov 19, 2026 vs $64.09 current
Highest Target$75.00
Average Target$68.00
Lowest Target$60.00
Detailed analyst forecasts for SMG
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 3 of 4 active firms rate SMG a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
SMG EPS & revenue forecast
EPS · NEXT QUARTER
$4.48
Range $4.39 – $4.61 · 6 analysts · -1% YoY
Next period, 6 analysts expect Scotts Miracle-Gro Company to earn $4.48 a share (range $4.39 – $4.61), versus $4.53 a year earlier. Full-year consensus is $4.79, growing to $5.19 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.5B – $1.5B · 6 analysts · +0% YoY
Revenue is expected to reach $1.5B (range $1.5B – $1.5B), +0.1% year-over-year. Full-year consensus is $3.4B, rising to $3.5B next year.
Top analysts covering Scotts Miracle-Gro Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SMG.
#1
Jeffrey Zekauskas
JP Morgan · Rank #114
Neutral
$70.00+9.2% to target
Overall win rate
51%
+ Follow
#2
Chris Carey
Wells Fargo · Rank #142
Buy
$60.00-6.4% to target
Overall win rate
46%
+ Follow
#3
Bill Chappell
Truist Securities · Rank #551
Buy
$80.00+24.8% to target
Overall win rate
25%
+ Follow
#4
Peter Grom
UBS
Buy
$70.00+9.2% to target
Coverage
—
+ Follow
#5
WA
W. Andrew Carter
Stifel
Buy
$75.00+17.0% to target
Coverage
—
+ Follow
SMG stock forecast FAQ
What is SMG's average 12-month price target?+
The 4 active firms with a live target average $68.00 for Scotts Miracle-Gro Company over the next 12 months, ranging from a $75.00 high to a $60.00 low, as of Nov 19, 2026.
Is SMG stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for SMG?+
The Street-high target is $75.00 (Stifel), and the Street-low is $60.00 (Wells Fargo). The average of all 4 active-firm targets is $68.00.
How many active Wall Street firms cover SMG?+
4 active firms have a recognized rating on Scotts Miracle-Gro Company as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering SMG?+
Among analysts who currently cover SMG, Jeffrey Zekauskas of JP Morgan has the strongest overall Quantellect track record (Rank #114). Their current call is Neutral with a $70.00 target.
What is Scotts Miracle-Gro Company's projected EPS for next quarter?+
The consensus estimate is $4.48 per share (range $4.39 – $4.61) across 6 analysts. Full-year EPS is projected at $4.79, rising to $5.19 the following year.
How much revenue is Scotts Miracle-Gro Company expected to report next quarter?+
Consensus revenue is $1.5B (range $1.5B – $1.5B). Full-year revenue is projected at $3.4B, growing to $3.5B next year.
Have analysts been upgrading or downgrading SMG lately?+
As of Nov 19, 2026, 3 of 4 active firms rate SMG a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SMG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.